Investing in drugmakers: uncommon profits from curing rare diseases
Investing in drugmakers: uncommon profits from curing rare diseases
Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
GlaxoSmithKline is set to cut its dividend – should you sell your shares?
GlaxoSmithKline is set to cut its dividend – should you sell your shares?
GlaxoSmithKline, a top pick for UK income investors, will reduce its dividend after spinning out its consumer healthcare business. So should you sell?…
22 Apr 2022
The mistakes pharmaceutical companies made with their Covid vaccines
The mistakes pharmaceutical companies made with their Covid vaccines
Covid-19 looked as if it would mark the start of a golden age for the pharmaceutical industry. It’s not worked out that way, says Matthew Lynn.
19 Mar 2022
Veterinary medicine stocks: the firms keeping your pet healthy
Veterinary medicine stocks: the firms keeping your pet healthy
Pet ownership has grown due to the pandemic. That’s good news for animal health stocks, says Dr Mike Tubbs
11 Mar 2022
How Covid-19 changed biotechnology – and how you can invest
How Covid-19 changed biotechnology – and how you can invest
The pandemic has exacted a huge human and financial toll, but it has also transformed scientific research in ways that will deliver huge benefits for …
4 Mar 2022
The best vaccine-makers’ stocks to buy now
The best vaccine-makers’ stocks to buy now
The rapid development of Covid-19 vaccines has already saved many lives and made huge profits for a few pharmaceutical firms. Investors should keep an…
13 Jan 2022
Three biotech stocks to buy now
Three biotech stocks to buy now
Professional investors Ailsa Craig and Marek Poszepczynski of the International Biotechnology Trust pick three of their favourite biotech stocks to bu…
10 Jan 2022
Subscribe to MoneyWeek and get your first six issues FREE
Subscribe to MoneyWeek now and get your first six magazine issues absolutely FREE
Get healthy returns from these three innovative healthcare stocks
Get healthy returns from these three innovative healthcare stocks
Professional investor Michael Li of the American Century Advanced Medical Impact Fund looks at three healthcare stocks
28 Dec 2021
Stéphane Bancel: Moderna’s biotech whizz who changed the world
Stéphane Bancel: Moderna’s biotech whizz who changed the world
Stéphane Bancel had a safe job as CEO of a French multinational when he decided to risk it all on a promising but unproven medical technology. The bet…
12 Dec 2021
The huge potential of mRNA technology
The huge potential of mRNA technology
The new technology made its name when it delivered Covid-19 vaccines in record time. But it could be pressed into use in many other areas too. Simon W…
28 Oct 2021
Get healthy returns from these three healthcare stocks
Get healthy returns from these three healthcare stocks
Professional investor Paul Major of the BB Healthcare Trust highlights three of his favourite healthcare stocks.
25 Oct 2021
University spin-outs: where to find companies involved in cutting-edge science
University spin-outs: where to find companies involved in cutting-edge science
Universities are innovation incubators and often launch businesses involved in fast-growing fields ranging from biotechnology to artificial intelligen…
24 Sep 2021
AstraZeneca’s Covid troubles could see it pull out of making vaccines
AstraZeneca’s Covid troubles could see it pull out of making vaccines
AstraZeneca has suffered a series of setbacks with its Covid-19 jab and may exit the inoculation subsector altogether. Matthew Partridge reports
6 Aug 2021
A great leap forward in the war against Alzheimer’s disease
A great leap forward in the war against Alzheimer’s disease
The approval of the first drug to treat the neurodegenerative disease in 18 years will galvanise research in the entire subsector, says Dr Mike Tubbs.…
16 Jul 2021
Shake-up at GSK won’t placate investors
Shake-up at GSK won’t placate investors
GSK has launched a radical shakeup of its operations, but that's unlikely to satisfy investors unhappy with the drugmaker's perennial underperformance…
2 Jul 2021
Two investment trusts that have proved their worth
Two investment trusts that have proved their worth
These two investment trusts have earned investors’ confidence since their flotations and remain solid bets, says Max King.
25 Jun 2021
Investing in stem cells, the building blocks of the body
Investing in stem cells, the building blocks of the body
Stem cells have always been tomorrow’s technology. But it looks as though their time has finally come – and they will transform the treatment of disea…
18 Jun 2021
Why Joe Biden’s Big Pharma patent grab is a terrible idea
Why Joe Biden’s Big Pharma patent grab is a terrible idea
The US president has proposed waiving patents on Covid-19 vaccines in a bid to boost global supply. But it won’t work on its own terms and holds dange…
22 May 2021
How to invest in the fight against Alzheimer’s disease
How to invest in the fight against Alzheimer’s disease
The cost of caring for those with dementia is a growing problem for healthcare systems around the world. Any firm that develops an effective treatment…
21 May 2021
A show of support for GlaxoSmithKline's hedge fund fight
A show of support for GlaxoSmithKline's hedge fund fight
Several large shareholders have said that they will support GlaxoSmithKline in its battle with hedge fund Elliott Management.
21 May 2021
How to invest in biotechnology: the healthcare sector’s high-growth area
How to invest in biotechnology: the healthcare sector’s high-growth area
Dr Mike Tubbs provides an overview of this thriving industry, whose latest triumphs include the Covid-19 vaccines. He examines the best investment str…
14 May 2021
Vaccine patents: a bitter pill for drug companies
Vaccine patents: a bitter pill for drug companies
The US has suggested waiving drug companies’ vaccine patents to hasten the defeat of Covid-19, sending their share prices down.
14 May 2021